# Life Biosciences Inc.

Life Biosciences Inc. is an other based in Boston, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Boston, United States
- **Region:** North America
- **Address:** 75 Park Plaza Level Three, Boston, MA 02116, United States
- **Assets under management:** Undisclosed
- **Website:** www.lifebiosciences.com
- **LinkedIn:** https://www.linkedin.com/company/lifebiosciences

## Regulatory record

- **Reports private funds:** No

## About

Rejuvenating cells to reverse age-related diseases. Life Biosciences is a biotechnology company pioneering cellular rejuvenation using epigenetic restoration to reverse diseases of aging.

## Sectors

- Biotechnology
- Digital Health

## Questions

### What is Life Biosciences' core technology?

Life Biosciences develops epigenetic restoration, a process that resets epigenetic marks to revert cells to a younger, healthier state. The company claims to be the only one with intellectual property covering the therapeutic use of this technology (per firm website). Its platform targets age-related diseases, with initial focus on optic neuropathies.

### How is Life Biosciences funded?

Life Biosciences raised an $80 million Series D in April 2026 (per firm press release, April 2026). The company does not disclose its full financing history or valuation. Ownership structure is not public.

### Who are Life Biosciences' executives or board members?

Life Biosciences' leadership team and board are not listed on the public website. The company appointed David Guyer, M.D. to the board in November 2025 (per firm newsroom, November 2025), but no other named principals are disclosed.

### What diseases does Life Biosciences target?

The company's initial clinical program targets optic neuropathies. Preclinical work includes liver disease and ocular diseases. The broader platform aims to address multiple age-related illnesses, though specific pipeline details beyond eye and liver programs are not public.

### Does Life Biosciences have any research collaborations?

In July 2025, Life Biosciences announced a research collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to expand its pipeline of cellular rejuvenation therapies (per firm newsroom, July 2025). No other collaborations are disclosed.

## Related profiles

- [HortonWorks](https://altss.com/profile/hortonworks-inc)
- [Ipca Laboratories Limited](https://altss.com/profile/ipca-laboratories-limited)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/life-biosciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology